Advertisement
Advertisement

NUTX

NUTX logo

Nutex Health Inc. Common Stock

99.75
USD
Sponsored
-2.22
-2.17%
Feb 06, 16:00 UTC -5
Closed
exchange

After-Market

99.81

+0.06
+0.06%

NUTX Earnings Reports

Positive Surprise Ratio

NUTX beat 7 of 12 last estimates.

58%

Next Report

Date of Next Report
Mar 25, 2026
Estimate for Q4 25 (Revenue/ EPS)
$263.99M
/
$6.97
Implied change from Q3 25 (Revenue/ EPS)
-1.42%
/
-10.18%
Implied change from Q4 24 (Revenue/ EPS)
+2.47%
/
-37.32%

Nutex Health Inc. Common Stock earnings per share and revenue

On Nov 19, 2025, NUTX reported earnings of 7.76 USD per share (EPS) for Q3 25, beating the estimate of 1.11 USD, resulting in a 597.97% surprise. Revenue reached 267.80 million, compared to an expected 218.09 million, with a 22.80% difference. The market reacted with a +26.87% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 5 analysts forecast an EPS of 6.97 USD, with revenue projected to reach 263.99 million USD, implying an decrease of -10.18% EPS, and decrease of -1.42% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
InnovAge Holding Corp. Common Stock
Report Date
Feb 03, 2026 For Q2 26
Estimate
$0.04
Actual
$0.08
Surprise
+96.08%
logo
Embecta Corp. Common Stock
Report Date
Feb 05, 2026 For Q1 26
Estimate
$0.68
Actual
$0.71
Surprise
+3.89%
logo
Danaher Corporation
Report Date
Jan 28, 2026 For Q4 25
Estimate
$2.17
Actual
$2.23
Surprise
+2.56%
logo
HCA Healthcare, Inc.
Report Date
Jan 27, 2026 For Q4 25
Estimate
$7.53
Actual
$8.14
Surprise
+8.05%
logo
Elevance Health, Inc.
Report Date
Jan 28, 2026 For Q4 25
Estimate
$3.12
Actual
$3.33
Surprise
+6.46%
logo
Cencora, Inc.
Report Date
Feb 04, 2026 For Q1 26
Estimate
$4.07
Actual
$4.08
Surprise
+0.16%
logo
Revvity, Inc.
Report Date
Feb 02, 2026 For Q4 25
Estimate
$1.58
Actual
$1.70
Surprise
+7.45%
FAQ
For Q3 2025, Nutex Health Inc. Common Stock reported EPS of $7.76, beating estimates by 597.97%, and revenue of $267.80M, 22.8% above expectations.
The stock price moved up 26.87%, changed from $112.19 before the earnings release to $142.34 the day after.
The next earning report is scheduled for Mar 25, 2026.
Based on 5 analysts, Nutex Health Inc. Common Stock is expected to report EPS of $6.97 and revenue of $263.99M for Q4 2025.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement